Kymera Therapeutics Inc

NASDAQ:KYMR   3:59:59 PM EDT
37.25
-0.97 (-2.54%)
Products

Kymera Therapeutics Announces FDA Clearance Of Investigational New Drug Application (Ind) For Irakimid Degrader, KT-413

Published: 11/30/2021 13:56 GMT
Kymera Therapeutics Inc (KYMR) - Kymera Therapeutics Announces FDA Clearance of Investigational New Drug Application (ind) for Irakimid Degrader, Kt-413.
Kymera Therapeutics Announces FDA Clearance of Investigational New Drug Application (ind) for Irakimid Degrader, Kt-413.